• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

    6/1/23 7:55:33 AM ET
    $AGBA
    $AI
    $ALOT
    $APLM
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology
    Get the next $AGBA alert in real time by email

    Gainers

    • Airspan Networks Holdings Inc. (NYSE:MIMO) shares rose 58.9% to $0.3754 in pre-market trading. Airspan Networks recently reported new financing and leadership changes.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares gained 50% to $0.1350 in pre-market trading after dropping 33% on Wednesday. T2 Biosystems recently announced the second-largest sepsis-driven T2Dx instruments sale in the company's history.
    • AGBA Group Holding Limited (NASDAQ:AGBA) shares surged 37.7% to $2.23 in pre-market trading after gaining around 9% on Wednesday.
    • Wejo Group Limited (NASDAQ:WEJO) gained 28.2% to $0.1090 in pre-market trading after declining around 31% on Wednesday. Wejo Group recently said it is evaluating whether to file ancillary insolvency proceedings for the company and other units in other jurisdictions, including the US.
    • VCI Global Limited (NASDAQ:VCIG) shares rose 28% to $3.47 in pre-market trading after gaining 7% on Wednesday. VCI Global said it will be subscribing for 500 new GlobexUS Holdings Corp shares at $3,000 per share for $1.5 million.
    • Hoth Therapeutics, Inc. (NASDAQ:HOTH) rose 24.1% to $1.96 in pre-market trading. EF Hutton assumed Buy rating and $14 price target on Hoth.
    • Chewy, Inc. (NYSE:CHWY) rose 17% to $34.50 in pre-market trading on the heels of a strong first-quarter report.
    • Apollomics, Inc. (NASDAQ:APLM) gained 15.1% to $4.66 in pre-market trading.
    • AstroNova, Inc. (NASDAQ:ALOT) shares climbed 12.5% to $17.97 in pre-market trading. AstroNova is expected to report its first-quarter fiscal 2024 financial results on June 8, 2023.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) shares gained 10.6% to $4.94 in pre-market trading. The China-based technology firm recently reported a first-quarter FY23 revenue of $271.48 million, missing the consensus of $282.80 million.

    Losers

    • C3.ai, Inc. (NYSE:AI) fell 20.4% to $31.85 in pre-market. C3.ai reported better-than-expected earnings and sales results for its first quarter. C3.ai also said it sees first-quarter revenue of $70 million to $72.5 million versus estimates of $71.56 million.
    • Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) shares dropped 19% to $0.3220 in pre-market trading. Aridis Pharmaceuticals shares jumped around 115% on Wednesday after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of AR-301 and the clinical study design..
    • Okta, Inc. (NASDAQ:OKTA) shares dropped 19% to $73.50 in pre-market trading despite strong first-quarter results.
    • Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) fell 17.6% to $1.73 in pre-market trading after jumping 20% on Wednesday.
    • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) fell 16.7% to $2.75 in pre-market trading after the company reported a proposed public offering of common stock.
    • VolitionRx Limited (NYSE:VNRX) fell 16.6% to $1.29 in pre-market trading after announcing a proposed underwritten public offering of common stock.
    • Victoria's Secret & Co. (NYSE:VSCO) shares fell 16% to $17.15 in pre-market trading after the company reported a sharp decline in first-quarter EPS.
    • IM Cannabis Corp. (NASDAQ:IMCC) fell 14.7% to $1.09 in pre-market trading after jumping around 20% on Wednesday.
    • QualTek Services Inc. (NASDAQ:QTEK) fell 13.7% to $0.0773 in pre-market trading. QualTek Services shares dropped over 40% on Wednesday after the company received a Nasdaq delisting notice.
    • VIQ Solutions Inc. (NASDAQ:VQS) fell 11.8% to $0.2644 in pre-market trading after gaining over 28% on Wednesday.

     

    Now Read This: Investor Sentiment Drops As Dow Records Loss For May

    Get the next $AGBA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGBA
    $AI
    $ALOT
    $APLM

    CompanyDatePrice TargetRatingAnalyst
    Okta Inc.
    $OKTA
    4/20/2026$90.00Equal Weight → Overweight
    Barclays
    Okta Inc.
    $OKTA
    4/16/2026$85.00Mkt Perform → Outperform
    Raymond James
    Okta Inc.
    $OKTA
    3/19/2026$100.00Outperform
    Macquarie
    Okta Inc.
    $OKTA
    3/6/2026$97.00Market Perform → Outperform
    BMO Capital Markets
    Okta Inc.
    $OKTA
    3/3/2026$76.00Equal Weight
    Wells Fargo
    Victorias Secret & Co.
    $VSCO
    3/2/2026$66.00 → $71.00Outperform
    Telsey Advisory Group
    C3.ai Inc.
    $AI
    2/26/2026Mkt Outperform → Mkt Perform
    Citizens
    Okta Inc.
    $OKTA
    2/26/2026$90.00 → $83.00Market Perform
    BMO Capital Markets
    More analyst ratings

    $AGBA
    $AI
    $ALOT
    $APLM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    FDA Approval for INPEFA issued to LEXICON PHARMACEUTICALS INC

    Submission status for LEXICON PHARMACEUTICALS INC's drug INPEFA (ORIG-1) with active ingredient SOTAGLIFLOZIN has changed to 'Approval' on 05/26/2023. Application Category: NDA, Application Number: 216203, Application Classification: Type 1 - New Molecular Entity

    5/30/23 10:02:49 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AI
    $ALOT
    $APLM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Debbane Raymond bought $2,980 worth of shares (2,000 units at $1.49), increasing direct ownership by 0.11% to 1,906,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/27/26 8:33:21 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Debbane Raymond bought $147,000 worth of shares (100,000 units at $1.47), increasing direct ownership by 6% to 1,904,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/25/26 7:00:27 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Debbane Raymond bought $219,755 worth of shares (150,000 units at $1.47), increasing direct ownership by 9% to 1,804,186 units (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/23/26 7:49:43 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AI
    $ALOT
    $APLM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Okta upgraded by Barclays with a new price target

    Barclays upgraded Okta from Equal Weight to Overweight and set a new price target of $90.00

    4/20/26 8:21:07 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    Okta upgraded by Raymond James with a new price target

    Raymond James upgraded Okta from Mkt Perform to Outperform and set a new price target of $85.00

    4/16/26 7:58:53 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    Macquarie initiated coverage on Okta with a new price target

    Macquarie initiated coverage of Okta with a rating of Outperform and set a new price target of $100.00

    3/19/26 8:26:35 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    $AGBA
    $AI
    $ALOT
    $APLM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 3 filed by new insider Liew Soo Hua

    3/A - VCI Global Ltd (0001930510) (Issuer)

    4/22/26 11:10:53 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    Amendment: SEC Form 3 filed by new insider Hoo Voon Him

    3/A - VCI Global Ltd (0001930510) (Issuer)

    4/22/26 11:10:27 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    Amendment: SEC Form 3 filed by new insider Lee Tze Wee

    3/A - VCI Global Ltd (0001930510) (Issuer)

    4/22/26 11:10:03 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    $AGBA
    $AI
    $ALOT
    $APLM
    SEC Filings

    View All

    SEC Form 20-F filed by Apollomics Inc.

    20-F - Apollomics Inc. (0001944885) (Filer)

    4/24/26 4:24:12 PM ET
    $APLM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Kingsoft Cloud Holdings Limited

    6-K - Kingsoft Cloud Holdings Ltd (0001795589) (Filer)

    4/23/26 7:28:22 PM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Kingsoft Cloud Holdings Limited

    6-K - Kingsoft Cloud Holdings Ltd (0001795589) (Filer)

    4/23/26 8:51:55 AM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    $AGBA
    $AI
    $ALOT
    $APLM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VolitionRx Announces Acceptance of Compliance Plan by NYSE American

    HENDERSON, Nev., April 23, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that on April 22, 2026, the NYSE American LLC (the "NYSE American") accepted the Company's plan of compliance for continued listing on the exchange. As previously reported, on February 6, 2026, the Company received a notice from the NYSE American stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the "Company Guide") requiring a company to have stockholders' equity of at least $2.0 million if it has reported losses fro

    4/23/26 8:12:00 AM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Kingsoft Cloud Files Annual Report on Form 20-F for Fiscal Year 2025 and Releases 2025 Environmental, Social and Governance Report

    BEIJING, April 23, 2026 /PRNewswire/ -- Kingsoft Cloud Holdings Limited ("we," "Kingsoft Cloud" or the "Company") (NASDAQ:KC), a leading cloud service provider in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission ("SEC") on April 23, 2026. The Company also published an annual report for the year ended December 31, 2025 (the "Hong Kong Annual Report")  pursuant to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "HKEx") on the same day. The annual report can be accessed on the Company's investor relations website at http://ir.ksyun.com as well

    4/23/26 7:20:00 AM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    Amaero Releases Quarterly Activities Report for the Period Ending March 2026

    MCDONALD, Tenn., April 21, 2026 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA, OTCX:AMROF) ("Amaero" or the "Company"), a leading producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing, and a leader in PM-HIP (Powder Metallurgy Hot Isostatic Pressing) manufacturing, is pleased to provide an overview of its operations to accompany the Appendix 4C for the quarter ending March 31, 2026. Amaero continued to execute on its manufacturing scale-up and commercial programs during the March quarter, making solid progress in production capacity, customer qualification, and corporate initiatives. Entering Q4 FY2026, the Company is well positioned to deliver a s

    4/21/26 8:00:00 AM ET
    $DRVN
    $EAT
    $VSCO
    Automotive Aftermarket
    Consumer Discretionary
    Restaurants
    Clothing/Shoe/Accessory Stores

    $AGBA
    $AI
    $ALOT
    $APLM
    Leadership Updates

    Live Leadership Updates

    View All

    Amaero Releases Quarterly Activities Report for the Period Ending March 2026

    MCDONALD, Tenn., April 21, 2026 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA, OTCX:AMROF) ("Amaero" or the "Company"), a leading producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing, and a leader in PM-HIP (Powder Metallurgy Hot Isostatic Pressing) manufacturing, is pleased to provide an overview of its operations to accompany the Appendix 4C for the quarter ending March 31, 2026. Amaero continued to execute on its manufacturing scale-up and commercial programs during the March quarter, making solid progress in production capacity, customer qualification, and corporate initiatives. Entering Q4 FY2026, the Company is well positioned to deliver a s

    4/21/26 8:00:00 AM ET
    $DRVN
    $EAT
    $VSCO
    Automotive Aftermarket
    Consumer Discretionary
    Restaurants
    Clothing/Shoe/Accessory Stores

    Tim Johnson Nominated to Join Amaero Board

    MCDONALD, Tenn., March 10, 2026 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTC:AMROF) ("Amaero" or the "Company"), a leading U.S. domestic producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing of components utilized by the defense, space, and aviation industries, is pleased to announce that Tim "TJ" Johnson has been nominated to join Amaero's Board as a Non-Executive Director, subject to satisfying the requisite regulatory requirements. Upon joining the Board as a Non-Executive Director, it is anticipated that he will assume the responsibilities of Chairman of the Audit and Risk Committee. Mr. Johnson is an experienced corporate board member

    3/10/26 8:00:00 AM ET
    $DLTR
    $DRVN
    $EAT
    Department/Specialty Retail Stores
    Consumer Discretionary
    Automotive Aftermarket
    Restaurants

    Victoria's Secret & Co. Reports 2025 Fourth Quarter and Full Year Results

    Fourth Quarter and Full Year Results Exceeded Top- and Bottom-line GuidanceComparable Sales Increased 8% in the Fourth Quarter and 5% for the Full YearFourth Quarter and Full Year Adjusted Operating Income Significantly Exceeded ExpectationsInitiates First Quarter and Fiscal 2026 Guidance REYNOLDSBURG, Ohio, March 05, 2026 (GLOBE NEWSWIRE) -- Victoria's Secret & Co. ("VS&Co" or the "Company") (NYSE:VSCO) today reported financial results for the fourth quarter and fiscal year ended January 31, 2026. Hillary Super, VS&Co Chief Executive Officer, said, "We delivered an exceptional fourth quarter and a standout year, exceeding top- and bottom-line guidance with broad based outperformance acr

    3/5/26 7:00:00 AM ET
    $VSCO
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AGBA
    $AI
    $ALOT
    $APLM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Lexicon Pharmaceuticals Inc.

    SC 13D/A - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    12/9/24 9:33:20 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by VCI Global Limited

    SC 13G - VCI Global Ltd (0001930510) (Subject)

    12/6/24 6:01:22 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by C3.ai Inc.

    SC 13G/A - C3.ai, Inc. (0001577526) (Subject)

    11/14/24 5:03:49 PM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    $AGBA
    $AI
    $ALOT
    $APLM
    Financials

    Live finance-specific insights

    View All

    AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

    Fourth quarter revenue of $37.5 million and fiscal 2026 revenue of $150.5 million, in line with guidance Fourth quarter net loss was $1.1 million, or $0.15 per diluted share; adjusted EBITDA1 was $3.3 million, or 8.8% of sales Product Identification turnaround gaining momentum with well-defined go-to-market and operations strategies Total orders in the quarter were up 6.5% to $41.1 million Generated $3.7 million of operating cash in the quarter and $11.7 million for the full year, compared with $2.5 million and $4.8 million in the prior periods, respectively Strengthened balance sheet with debt reduced by $2.7 million in the quarter and $9.1 million in fiscal 2026 Previou

    4/13/26 4:30:00 PM ET
    $ALOT
    Computer peripheral equipment
    Technology

    VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update

    Conference call to discuss financial and operational results scheduled forWednesday, April 1 at 8:30 a.m. U.S. Eastern TimeHENDERSON, Nev., March 31, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announces financial results and a business update for the full fiscal year 2025.  Volition management will host a conference call tomorrow, April 1 at 8:30 a.m. U.S. Eastern Time/2:30 p.m. Central European Time to discuss these results. Conference call details can be found below. Cameron Reynolds, President and Group Chief Executive Officer, said:"We set out over fifteen years ago to help save lives and improve outcomes for millions of

    3/31/26 4:05:00 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    AstroNova Announces Fourth Quarter & Fiscal Year 2026 Financial Results Conference Call and Webcast

    AstroNova, Inc. (NASDAQ:ALOT), a leading innovator in specialized print technology solutions, announced today that it will release its fourth quarter and fiscal year 2026 financial results after the market close on Monday, April 13, 2026. The Company will conduct a conference call and webcast before market the next day to review its financial and operating results and discuss its corporate strategies and outlook. The call will be hosted by Jorik Ittmann, President and Chief Executive Officer, and Tom DeByle, Vice President, Chief Financial Officer & Treasurer. A question-and-answer session will follow. Fourth Quarter & Fiscal Year 2026 Conference Call Date: Tuesday, April 14,

    3/26/26 9:25:00 AM ET
    $ALOT
    Computer peripheral equipment
    Technology